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• G protein-coupled receptors (GPCRs) are proteins that are 
important in physiological regulatory processes within the body, and 
for this reason are important drug targets
• When bound to an agonist, such as neurotransmitters or hormones, 
the receptor adopts an active state to allow these biochemical 
pathways to occur
• Mutations can arise within the receptor that affect its ability to bind 
its agonist
• Purpose: To test whether mutations within the sodium ion binding 
pocket, an allosteric site, play a role in agonist-induced receptor 
activation
• Hypothesis: If mutations are made within the sodium ion binding 
site, then there will be an increase in agonist-induced receptor 
activation due to the loss of a negative allosteric effect
• A GloSensor cAMP assay was used to measure luminescence, 
which was a direct output of receptor activation
• HEK293H cells were co-transfected with mutant and wildtype 
receptors, as well as a GloSensor plasmid
• Agonist binding encouraged the production of cAMP, which when 
present with luciferin, caused luminescence to occur
• S91A remained active, indicating that there is still agonist-induced activation 
that occurs
• There was reduced spontaneous activity when comparing the two time
course graphs
• The dose response curve show similar responsiveness between the 
wildtype and mutant receptor
• In summary, mutations with the sodium ion binding site play a role in the 
ability of the agonist to bind the receptor
• Our findings go against those found in literature as well as our original 
hypothesis, as there was a decrease in agonist-induced receptor activation, 
instead of an increase
• More research must be completed to fully understand this concept
Introduction
Methods
Figure 1. GloSensor Assay. Luminescence from luciferase 




Figure 2. Spontaneous activity of wildtype receptor (A) and mutant receptor S91A 
(B) in the form of a time course graph. Luminescence output over time is a direct
measurement of agonist-binding. It is calculated using the slopes of the data. Activity is 
reduced in S91A.
Figure 3A. The rate of cAMP production as a function of adenosine concentration, 
normalized to 1.0. WT response is the blue curve while mutant response is the red curve. 
There is no significant difference between the two curves.
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